FIELD: monitoring and measurement equipment.
SUBSTANCE: invention relates to the field of the blood and its components characteristics studying, in particular their coagulating property. Blood and its components spatial coagulation studying device contains the thermostatically controlled chamber with the thermal stabilization unit, inside which container with the test sample and the activator, LEDs, and recording module with a video camera are placed. At that, container with the test sample is a tray with wells, onto which side surface an activator is applied, and the bottom is made flat and transparent, recording module is placed in the thermostatically controlled chamber under the tray wells with possibility of movement in the horizontal plane along two perpendicular directions and is provided with the hole bottom circular illumination unit, which is a disk with a central hole and concentrically mounted thereon LEDs, and a plate with a coaxial hole that forms a light cone under the hole bottom, at that, the temperature control is made with air, and the temperature-controlled chamber inner surface has a corrugated coating from light-absorbing material.
EFFECT: invention provides increase in the performance and increase in the conducted analyses accuracy, reduction in the study complexity and the analysis cost.
4 cl, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
DEVICE FOR HEMOSTASIS STATUS DIAGNOSTICS | 2019 |
|
RU2722825C1 |
DEVICE FOR MEASUREMENT OF HEMOSTASIS PARAMETERS | 2022 |
|
RU2779368C1 |
ANALYSIS DEVICE FOR SPATIAL COAGULATION OF BLOOD AND COMPONENTS THEREOF | 2008 |
|
RU2395812C2 |
METHOD OF DETERMINING SPACE-TIME DISTRIBUTION OF PROTEOLYTIC ENZYME ACTIVITY IN HETEROGENEOUS SYSTEM, DEVICE FOR REALISING THEREOF AND METHOD OF DIAGNOSING HEMOSTASIS SYSTEM DISORDERS BY CHANGE OF SPACE-TIME DISTRIBUTION OF PROTEOLYTIC ENZYME ACTIVITY IN HETEROGENIC SYSTEM | 2011 |
|
RU2518247C2 |
ANALYSIS TRAY FOR SPATIAL COAGULATION OF BLOOD AND COMPONENTS THEREOF | 2008 |
|
RU2395811C2 |
METHOD FOR DETERMINING FACTOR XIII ACTIVITY | 2001 |
|
RU2204141C2 |
METHOD FOR DETERMINING FIBRINOGEN DURING RECALCIFICATION OF CITRATE PLASMA AND EVALUATING ITS FUNCTIONALITY | 2019 |
|
RU2703541C1 |
DEVICE FOR BIOLOGICAL RESEARCH | 2018 |
|
RU2673745C1 |
REAGENT KIT FOR DIAGNOSING DEGREE OF NEUROINFLAMMATION | 2018 |
|
RU2698206C1 |
HIGHLY-SELECTIVE INFESTIN 4-BASED INHIBITOR OF CONTACT ACTIVATION | 2013 |
|
RU2556116C2 |
Authors
Dates
2019-03-22—Published
2018-04-02—Filed